Clinical Trials
25 trialsA Real-world Study in Participants With Smoldering Multiple Myeloma
Janssen-Cilag Ltd.
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Dana-Farber Cancer Institute
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Dana-Farber Cancer Institute
PNRR-2022-1237
Azienda USL Reggio Emilia - IRCCS
Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
M.D. Anderson Cancer Center
ProDigALIty
Fondazione IRCCS Policlinico San Matteo di Pavia
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
M.D. Anderson Cancer Center
TRANSFORMM
University of Miami
SPOTLIGHT
University of Utah
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
Wake Forest University Health Sciences
EMN36
European Myeloma Network B.V.
Registry for Adults With Plasma Cell Disorders (PCD's)
UNC Lineberger Comprehensive Cancer Center
The Indiana Myeloma Registry
Indiana University
LOOMIS
Oxford University Hospitals NHS Trust
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
Tufts Medical Center
ONCO-MRI
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
OxPLoreD
University of Oxford
Screening to Improve Survival in AL Amyloidosis
Tufts Medical Center
HMvax-Regist
Wake Forest University Health Sciences
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
Peking University First Hospital
COSMOS
University College, London
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
HealthTree Foundation
GENOMGUS
Rennes University Hospital
Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)
National Institutes of Health Clinical Center (CC)
S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.
SWOG Cancer Research Network